Abstract:OBJECTIVE:To observe the effect of microRNA-155 (miR-155) on the inflammatory response of rat alveolar macrophages induced by lipopolysaccharide (LPS). METHODS:The alveolar macrophages NR8383 of rat were cultured in vitro, the macrophages in logarithmic growth phase were harvested to conduct experiment. (1) The 1 mg/L LPS was used to stimulate the rat alveolar macrophages for 3, 6, 12, and 24 hours, a phosphate buffer solution (PBS) control group was also set up. Enzyme linked immunosorbent assay (ELISA) was used to detect the dynamic changes of interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) in the supernatant, and real-time quantitative reverse transcription-polymerase chain reaction (RT-qPCR) was used to detect the dynamics expression of miR-155 in the cells, which confirmed the optimal time for LPS stimulation was 12 hours. (2) Carboxyfluorescein (FAM) labeled mimic (FAM mimic) and inhibitor (FAM inhibitor) were used to transfect the alveolar macrophage, and the transfection effect was observed under inverted fluorescence microscope 6 hours later to confirm the optimal transfection concentration of mimic was 20 nmol/L, and the optimal transfection concentration of inhibitor was 100 nmol/L. miR-155 mimic and miR-155 inhibitor were transfected to alveolar macrophages respectively at the optimal transfection concentration for 24 hours, and 1 mg/L LPS was used to stimulate the cells for 12 hours. A mimic negative control + LPS group and an inhibitor negative control + LPS group were set up. The expressions of IL-1β and TNF-α in the supernatant were determined by ELISA to observe the regulation of miR-155 on inflammatory response of alveolar macrophages. RESULTS:(1) After stimulation of 1 mg/L LPS on alveolar macrophages, the contents of IL-1β and TNF-α in the supernatant and the expression of miR-155 in the cells were increased gradually with time prolongation, IL-1β and TNF-α contents peaked at 12 hours, and the expression of miR-155 peaked at 24 hours [as compared with PBS control group, IL-1β (ng/L): 910.43±36.09 vs. 22.66±7.84, TNF-α (ng/L): 3 138.39±394.10 vs. 233.92±8.84, miR-155 (2-ΔΔCt): 7.82±0.30 vs. 1, all P < 0.05]. (2) Under inverted fluorescence microscope, after 20 nmol/L FAM mimic or 100 nmol/L FAM inhibitor transfected alveolar macrophages for 6 hours, a large number of cells showed green fluorescence, indicating that the transfection was successful. The expression of miR-155 in the cells transfected with 20 nmol/L miR-155 mimic was up-regulated by (236.73±46.49) times as much as that in the negative control group (P < 0.05), and the levels of IL-1β and TNF-α in the supernatant of the cells stimulated by 1 mg/L LPS for 12 hours were significantly lower than those in the negative control group [IL-1β (ng/L): 324.37±36.59 vs. 799.31±39.44, TNF-α (ng/L): 1 554.01±342.48 vs. 3 020.49±418.30, both P < 0.05]. The miR-155 activity was significantly inhibited in the cells transfected with 100 nmol/L miR-155 inhibitor, and the expression of miR-155 was decreased by (4.00±3.26)% as compared with the negative control group, but the difference was not statistically significant (P > 0.05), and the levels of IL-1β and TNF-α in the supernatant of the cells stimulated by 1 mg/L LPS for 12 hours were significantly higher than those in the negative control group [IL-1β (ng/L): 1 358.98±212.04 vs. 878.68±53.42, TNF-α (ng/L): 4 225.57±281.11 vs. 2 881.32±286.08, both P < 0.05]. CONCLUSIONS:In LPS induced inflammatory response of alveolar macrophages, miR-155 plays an obvious inhibitory role.

Effects of microRNA-155 on interleukin-1 receptor-associated kinase 1 and 4 mRNA expression in liver injury of endotoximia mice

Effect of microRNA-155 agonist on inflammatory response during liver injury in septic mice

Effects of microRNA-155 inhibitor on JAK/STAT1 signaling pathway in lipopolysaccharide-induced lung injury

[Effects of Microrna-155 on Mice with Lipopolysaccharide-Induced Acute Lung Injury].

Effect of Ercao Qinggan Decoction on Acute Liver Injury of Mice with Endotoxemia and the Expression of TLR4 in the Liver

The effect of histone deacetylase inhibitor ACY1215 on the inflammatory response in mice with acute liver failure

Inhibition of microRNA‑155 relieves sepsis‑induced liver injury through inactivating the JAK/STAT pathway

A Role of Microrna‐370 in Hepatic Ischaemia‐reperfusion Injury by Targeting Transforming Growth Factor‐β Receptor II

[Protective Effect of Microrna-155 Antisense Oligonucleotid on Lipopolysaccharide-Induced Acute Lung Injury in Mice].

Inhibition of Microrna-155 Alleviates Lipopolysaccharide-Induced Kidney Injury in Mice

Regulation of hepatic microRNA expression in response to ischemic preconditioning following ischemia/reperfusion injury in mice.

Downregulation of TLR4 by Mir-181A Provides Negative Feedback Regulation to Lipopolysaccharide-Induced Inflammation

The expression profile and roles of microRNA in tumor necrosis factor α-mediated acute liver failure in mouse model

Mcpip1 Regulates Ror Expression To Protect Against Liver Injury Induced By Lipopolysaccharide Via Modulation Of Mir-155

Fine-Tuning the Expression of Microrna-155 Controls Acetaminophen-Induced Liver Inflammation

[Microrna-155 Reduces Inflammatory Response Induced by Lipopolysaccharide in Alveolar Macrophages].

MIR-155 PROMOTES ACUTE ORGAN INJURY IN LPS-INDUCED ENDOTOXEMIC MICE BY ENHANCING CCL-2 EXPRESSION IN MACROPHAGES.

Mir-497A-5p Attenuates Lipopolysaccharide-Induced Inflammatory Injury by Targeting IRAK2.

MicroRNA-155 deficiency attenuates ischemia-reperfusion injury after liver transplantation in mice.

Effects of MicroRNA-146b on Inflammatory Response and Organ Injury in Septic Mice

Mir-146A is Essential for Lipopolysaccharide (Lps)-Induced Cross-Tolerance Against Kidney Ischemia/reperfusion Injury in Mice